Pursuing IRF4 as a therapeutic opportunity for lymphoid malignancies

Researchers

Grant status

Active

Grant start date

01/01/2022

Grant funding

  • 2022: $388,671 from National Health and Medical Research Council (NHMRC)
  • 2023: $373,961 from National Health and Medical Research Council (NHMRC)
  • 2024: $416,652 from National Health and Medical Research Council (NHMRC)
  • 2025: $254,947 from National Health and Medical Research Council (NHMRC)

Updated:  06 July 2022 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers